Parabilis Medicines, Inc. (PBLS) stock
Close on Nov 12, 2026Market cap $3.42BP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $3.42B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.41
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $8.13
- Diluted shares
- 124M
Trading
- Previous close
- $29.65
- Open
- $29.54
- Day's range
- $27.47 – $29.88
- Volume
- 806,101
- Average volume (20 days)
- 1,067,750
- RSI (14 days)
- 46.3
- Relative volume
- 1.03×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | PBLS | S&P 500 | Difference | PBLS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.4% | -2.7% | −1.7 pts | ||
| 3 months | -26.0% | -1.7% | −24.2 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Parabilis Medicines filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
Parabilis Medicines stock: common questions
What is Parabilis Medicines's stock price?
PBLS closed at $27.69 on Nov 12, 2026, down 6.61% on the day.
What is Parabilis Medicines's market cap?
Parabilis Medicines was worth $3.42B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
Does Parabilis Medicines pay a dividend?
No. Parabilis Medicines has not paid a cash dividend over the last twelve months.
How many PBLS shares are sold short?
11M shares were sold short at the latest FINRA report, 12.78% of the float, or 8.3 days of average trading volume.
Who are Parabilis Medicines's competitors?
Companies most similar to Parabilis Medicines by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?